BUDGET 2025:  South Africa's Dependency on Foreign Aid: All Eyes on Gondongwana’s Defining Budget

Loading player...
GUEST: Natashia Soopal, Senior Executive: Ethics Standards and Public Sector, South African Institute of Chartered Accountants.

As South Africa prepares for the Minister of Finance, Mr Enoch Godongwana’s upcoming budget speech, the nation faces a crucial question. What kind of budget will we hear, and how will it shape the future? This isn’t just another financial update—it’s a pivotal moment, especially in the wake of US President Donald Trump’s recent announcement to cut funding to South Africa.

This raises fresh concerns about economic stability in an already struggling economy and further straining diplomatic relations - should this serve as a wakeup call for us?

Trump’s actions highlight the country’s precarious dependency on foreign aid, particularly in areas like HIV/AIDS treatment. In 2023, the US provided about $440 million through PEPFAR, covering 17% of South Africa’s HIV/AIDS programme. The potential loss of this funding would devastate healthcare delivery, threatening clinics, nursing staff, and the distribution of life-saving medications.

Even more concerning is the R46.25 billion in irregular healthcare spending over the past five years, alongside R5.55 billion in unauthorised expenditures. These financial inefficiencies not only compromise the already struggling healthcare system but raise questions about the long-term viability of crucial programmes should foreign aid be withdrawn.
10 Feb 2025 1PM English South Africa Business News · Investing

Other recent episodes

Why Women’s Financial Empowerment Is an Economic Multiplier

Women’s financial empowerment has the potential to drive economic growth, strengthen households and create lasting generational wealth. Kaya Biz speaks to Alexandra Nortier, Joint Head of Wealth Management at Investec Wealth & Investment International, about why Investec is backing the JSE SheInvests 2026 initiative, the barriers keeping women out of…
23 Jul 1PM 7 min

Affordable Diabetes Care Arrives in SA with Novo Nordisk

Novo Nordisk South Africa GM Sara Norcross explains the launch of the country’s only authorised copy of semaglutide, manufactured using the identical API, process and device as the originator — but at a more affordable price. We unpack what an authorised copy is, why SAHPRA registration matters, how the Acino…
23 Jul 1PM 14 min

SARB holds rates steady in July MPC – What It Means for You

Momentum economist Tshiamo Masike unpacks the SARB’s decision to pause, the upside inflation surprise, and the global factors driving the MPC’s decision. We explore how rising oil prices, geopolitical tensions, and weakening consumer confidence shaped the call — and what households, businesses and markets should expect next. A sharp, data‑driven…
23 Jul 1PM 14 min

PIC Board Exodus: Khaya Sithole on SA’s Biggest Asset Manager in Crisis

Six PIC directors have resigned, Treasury has begun steps to remove others, and whistleblower allegations of interference are mounting. Independent analyst Khaya Sithole breaks down the governance crisis unfolding at the Public Investment Corporation, what’s driving the board exodus, and what this means for the R2.5 trillion in assets the…
22 Jul 1PM 14 min

SA July MPC preview: Rates Outlook amid Hot Inflation

With inflation rising to 5.0%, fuel prices surging, and administered costs climbing, the SARB’s Monetary Policy Committee faces a tough call. Sanlam Investments economist Patrick Buthelezi unpacks today’s CPI print, the risks driving inflation, and what to expect from tomorrow’s MPC meeting. Essential listening for anyone watching interest rates and…
22 Jul 1PM 15 min